Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway

Histology and Histopathology

Volumn 28, Issue 12, 2013, Pages 1629-1638

  Yu, Weidong ^a   Ma, Shuyun ^a   Wang, Lihong ^a   Zuo, Bo ^a   Li, Mei ^a   Qiao, Zhengguo ^a   Pan, Xiuying ^a   Liu, Yulan ^a   Wang, Jingtong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

G protein coupled receptor 34 (GPR34); Gastric cancer; Metastasis; Prognosis

Indexed keywords

ELAFIN; G PROTEIN COUPLED RECEPTOR 34; G-PROTEIN-COUPLED RECEPTOR 34; LYSOPHOSPHOLIPID RECEPTOR; PI3 PROTEIN, HUMAN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL TRANSFERRING) KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH TUMOR; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; DISEASE PROGRESSION; ELAFIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LYSOPHOSPHOLIPID; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84888092529     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Anderson W.F., Camargo M.C., Fraumeni J.F., Correa P., Rosenberg P.S. and Rabkin C.S. (2010). Age-specific trends in incidence of noncardia gastric cancer in US adults, JAMA 303, 1723-1728.
2. Baens M., Finalet Ferreiro J., Tousseyn T., Urbankova H., Michaux L., de Leval L., Dierickx D., Wolter P., Sagaert X., Vandenberghe P., De Wolf-Peeters C., and Wlodarska I. (2012). t (X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34. Haematologica 97, 184-188.
3. Bédard A., Tremblay P., Chernomoretz A. and Vallières L. (2007). Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation. Glia 55, 77-789.
4. Cui M., Yu W., Dong J., Chen J., Zhang X. and Liu Y. (2010). Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma. Med. Oncol. 27, 632-639.
5. D'Ugo D., Persiani R., Zoccali M., Cananzi F., Vigorita V., Mazzeo P., Tufo A. and Biondi A. (2010). Surgical issues after neoadjuvant treatment for gastric cancer, Eur. Rev. Med. Pharmacol. Sci. 14, 315-319.
6. Engemaier E., Römpler H., Schöneberg T. and Schulz A. (2006). Genomic and supragenomic structure of the nucleotide-like Gprotein-coupled receptor GPR34. Genomics 87, 254-264.
7. Frasch S.C., Zemski-Berry K., Murphy R.C., Borregaard N., Henson P.M. and Bratton D.L. (2007). Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A. J. Immunol. 178, 6540-6548.
8. Gao Y., Kitagawa K., Hiramatsu Y., Kikuchi H., Isobe T., Shimada M., Uchida C., Hattori T., Oda T., Nakayama K., Nakayama K.I., Tanaka T., Konno H. and Kitagawa M. (2006). Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis, Cancer Res. 66, 11623-11631.
9. Hamilton S.R. and Aaltonen L.A. (2000). Pathology and genetics of tumors of digestive system. In: WHO classification of tumors. Hamilton S.R. and Aaltonen L.A. (eds). IARC Press. Lyon. pp 38.
10. Hamm A., Veeck J., Bektas N., Wild P.J., Hartmann A., Heindrichs U., Kristiansen G., Werbowetski-Ogilvie T., Del Maestro R., Knuechel R. and Dahl E. (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer 28; 8, 25.
11. Hamoudi R.A., Appert A., Ye H., Ruskone-Fourmestraux A., Streubel B., Chott A., Raderer M., Gong L., Wlodarska I., De Wolf-Peeters C., MacLennan K.A., de Leval L., Isaacso n P.G. and Du M.Q. (2010). Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism, Leukemia 24, 1487-1497.
12. Hejna M., Wohrer S., Schmidinger M., Raderer M. (2006). Postoperative chemotherapy for gastric cancer. Oncologist 11, 136-145.
13. Iwashita M., Makide K., Nonomura T., Misumi Y., Otani Y., Ishida M., Taguchi R., Tsujimoto M., Aoki J., Arai H. and Ohwada T. (2009). Synthesis and evaluation of lysophosphatidylserine analogues as inducers of mast cell degranulation. Potent activities of lysophosphatidylthreonine and its 2-deoxy derivative. J. Med. Chem. 52, 5837-5863.
14. Lee S.Y., Lee H.Y., Kim S.D., Jo S.H., Shim J.W., Lee H.J., Yun J. and Bae Y.S. (2008). Lysophosphatidylserine stimulates chemotactic migration in U87 human glioma cells. Biochem. Biophys. Res. Commun. 374, 147-151.
15. Mullaney P.J., Wadley M.S., Hyde C., Wyatt J., Lawrence G. and Hallissey M.T. (2002). Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer. Br. J. Surg. 89, 1405-1408.
16. Qin J., Xie Y., Wang B., Hoshino M., Wolff D.W., Zhao J., Scofield M.A., Dowd F.J., Lin M.F. and Tu Y. (2009). Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis, Oncogene 28, 1853-1863.
17. Qin Y., Verdegaal E.M., Siderius M., Bebelman J.P., Smit M.J., Leurs R., Willemze R., Tensen C.P. and Osanto S. (2011). Quantitative expression profiling of G protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target, Pigment Cell. Melanoma Res 24, 207-218.
18. Sugo T., Tachimoto H., Chikatsu T., Murakami Y., Kikukawa Y., Sato S., Kikuchi K., Nagi T., Harada M., Ogi K., Ebisawa M. and Mori M. (2006). Identification of a lysophosphatidylserine receptor on mast cells, Biochem. Biophys. Res. Commun. 341, 1078-1087.
19. You W.C., Brown L.M., Zhang L., Li J.Y., Jin M.L., Chang Y.S., Ma J.L., Pan K.F., Liu W.D., Hu Y., Crystal-Mansour S., Pee D., Blot W.J., Fraumeni J.F., Xu G.W. and Gail M.H. (2006). Randomized doubleblind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions, J. Natl. Cancer. Inst. 98, 974-983.